a moment of boredom I came across the latest release of 'the Street.com's Biotech Mailbag,' a biotech column where readers interact with the host, Adam Feuerstein, by sending in questions about biotech stocks which Feuerstein answers in the form of his column.

I used to follow the mailbag every week, just as I used to watch Jim Cramer's CNBC show 'Mad Money', but it didn't take me long to realize that both Cramer and Feuerstein had their own agenda- and looking out for the little guy wasn't part of it.


Read more

Shares of Biovest International Inc (BVTI.pk) opened the week significantly higher on news that the company's investigational cancer vaccine, BiovaxID, extended the lives of patients treated for follicular non-Hodgkin’s lymphoma.

According to the data presented at the American Society of Clinical O...

Read more